Elsevier

Human Pathology

Volume 29, Issue 9, September 1998, Pages 992-999
Human Pathology

Original contribution
Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors

https://doi.org/10.1016/S0046-8177(98)90206-4Get rights and content

Abstract

Carcinoid tumors are potentially malignant neoplasms that arise in various body sites, including the lung and gastrointestinal tract. Those that appear cytologically atypical are more likely to behave aggressively than more typical carcinoid tumors. However, in the absence of cytological atypia or large tumor size, it is difficult to predict the biology of an individual tumor, because some lesions metastasize, whereas others do not. This study had four aims: (1) To study the expression pattern of p53, Ki-67, NCAM, and S-100 in carcinoid tumors and to relate these expression patterns to classical histopathologic features and to tumor location. (2) To identify nonhistological markers that might more accurately predict the early behavior of carcinoid tumors. (3) To determine whether sustentacular cells are present in carcinoid tumors arising in tissues derived from different embryological derivatives. (4) To determine the synaptophysin and chromogranin immunoreactivity in neuroendocrine tumors arising in various locations. The immunostaining reactions were quantitatively scored by three observers. Only 3 of the 39 tumors (all histologically atypical) were strongly positive for Ki-67; two of these were also strongly p53 immunoreactive. NCAM immunostaining differed according to the site of origin: 76.5% of foregut lesions, 58% of the midgut lesions, and 20% of hindgut lesions were positive. S-100 immunostaining ranged from 41% in foregut lesions to 50% in both the hindgut- and midgut-derived tumors. S-100-positive sustentacular cells were present in 20.5% of carcinoid tumors. All tumors stained with antibodies against synaptophysin. In contrast, 100% of midgut, 60% of hindgut, and 88% of foregut tumors were chromogranin positive. Carcinoid tumors tend to have low proliferative rates. p53 immunostaining tends to be strongly positive in tumors that are histologically atypical, but it is negative in typical carcinoid tumors arising in the gastrointestinal tract and lungs. Immunostaining reactions with antibodies to NCAM, S-100, and chromogranin differ depending on the site of origin. Synaptophysin stains 100% of carcinoid tumors regardless of their site of origin. In contrast, antibodies to chromogranin fail to stain 40% of hindgut tumors and 12% of foregut carcinoid tumors. S-100-positive sustentacular cells are present in foregut and midgut tumors but not in hindgut tumors.

References (44)

  • S Obendorfer

    Karzinoide Tumoren des Dunndarms

    Frankfurt Pathol

    (1907)
  • J Gerdes et al.

    Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

    J Immunology

    (1984)
  • A Chaudhry et al.

    A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system

    Tumor Biol

    (1992)
  • J Bartek et al.

    Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies

    Oncogene

    (1991)
  • D Wynford-Thomas

    p53 in tumor pathology: Can we trust immunohistochemistry?

    J Pathol

    (1992)
  • P Unger et al.

    S-100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas

    Arch Pathol Lab Med

    (1991)
  • M Goddard et al.

    The histogenesis of appendiceal carcinoid tumors

    Histopathology

    (1991)
  • R Michalides et al.

    NCAM and lung cancer

    Int J Cancer Suppl

    (1994)
  • J Soga et al.

    Pathologic analysis of carcinoids: Histologic reevaluation of 62 cases

    Cancer

    (1971)
  • LA Johnson et al.

    Carcinoids: The association of histologic growth patterns and survival

    Cancer

    (1983)
  • RR Paladugu et al.

    Bronchopulmonary Kulchitzky cell carcinoma

    Cancer

    (1985)
  • J Zietels et al.

    Carcinoid tumors: A 37-year experience

    Arch Surg

    (1982)
  • Cited by (98)

    • Ki-67 antigen in lung neuroendocrine tumors: Unraveling a role in clinical practice

      2014, Journal of Thoracic Oncology
      Citation Excerpt :

      Significant differences in the Ki-67 LI distribution have been described in several studies between TC and AC,58–60,64–66,68,69,71,72,79 between LCNEC and SCLC,64 or across the entire spectrum of lung NE tumors,81 whereas other authors did not support this correlation at all56,70,75 or limited the failure to poorly differentiated NE tumors only.60 Proposed cutoff thresholds of Ki-67 LI ranged from 2.5 to approximately 30% for carcinoids,58,59,62,64–66,68,69,75,76,79,82 with two studies detecting 50% or more in few AC,68,70 whereas the separation of SCLC and LCNEC, if any,64 is of more limited clinical impact.1,86 In another study on 190 lung NE tumors published in an abstract form only, although there were differences in Ki-67 LI among diverse tumor categories, the incorporation of this marker as a primary criterion in the classification scheme of lung NE tumors was not further supported.85

    View all citing articles on Scopus
    View full text